| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ocugen, Inc. | Director | Option (Right to Buy) | 151,316 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OCGN | Ocugen, Inc. | 05 Jun 2025 | 0 | $0 | 3/A | Director | 12 Jun 2025, 16:28 |
| OCGN | Ocugen, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 17:19 |
| STAB | Statera Biopharma, Inc. | 22 Feb 2022 | 0 | $0 | 3 | Director | 21 Mar 2022, 19:27 |